GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/4/2026 4:20:35 PM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $761,000 +294.3% | Assets $1,213,271,000 | EPS -$0.90 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/4/2026 4:07:30 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $761,000 +294.3% | Assets $1,213,271,000 | EPS -$0.90 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/5/2026 4:14:00 PM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $463,000 -60.2% | Assets $1,246,884,000 | EPS -$0.85 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/5/2026 4:11:47 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $463,000 -60.2% | Assets $1,246,884,000 | EPS -$0.85 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 4/9/2026 4:12:02 PM | View | Proxy | SEC | Y 2025 | ||||||
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/9/2026 7:32:27 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $2,036,000 -67.3% | Assets $530,922,000 | EPS -$4.20 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/9/2026 7:19:50 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $284,000 -78.6% | Assets $530,922,000 | EPS -$1.52 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 1/12/2026 9:03:15 AM | View | Conf. Call | SEC | Y 2025 | ||||||
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/5/2025 4:23:42 PM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $396,000 -81.8% | Assets $577,445,000 | EPS -$0.97 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/5/2025 4:04:59 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $396,000 -81.8% | Assets $577,445,000 | EPS -$0.97 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/7/2025 4:25:05 PM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $193,000 -89.6% | Assets $326,076,000 | EPS -$0.88 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/7/2025 4:10:29 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $193,000 -89.6% | Assets $326,076,000 | EPS -$0.88 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/12/2025 4:23:55 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,163,000 +33.1% | Assets $348,580,000 | EPS -$0.82 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/12/2025 4:18:03 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,163,000 +33.1% | Assets $348,580,000 | EPS -$0.82 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 4/10/2025 4:32:13 PM | View | Proxy | SEC | Y 2024 | ||||||
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/11/2025 4:16:52 PM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $6,235,000 +120.6% | Assets $374,008,000 | EPS -$2.55 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/11/2025 4:04:52 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $1,326,000 +190.2% | Assets $374,008,000 | EPS -$0.82 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/7/2024 4:24:04 PM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,172,000 +135.1% | Assets $354,248,000 | EPS -$0.74 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/7/2024 4:07:54 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,172,000 +135.1% | Assets $354,248,000 | EPS -$0.74 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/8/2024 4:27:04 PM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $1,863,000 +92.3% | Assets $368,959,000 | EPS -$0.51 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 8/8/2024 4:08:57 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $1,863,000 +92.3% | Assets $368,959,000 | EPS -$0.51 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/9/2024 4:36:43 PM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $874,000 +83.6% | Assets $382,462,000 | EPS -$0.54 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 5/9/2024 4:15:47 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $874,000 +83.6% | Assets $382,462,000 | EPS -$0.54 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 4/11/2024 4:07:39 PM | View | Proxy | SEC | Y 2023 | ||||||
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/21/2024 4:15:49 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $2,826,000 -56.0% | Assets $179,405,000 | EPS -$8.45 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 3/21/2024 4:05:18 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $457,000 -61.1% | Assets $179,405,000 | EPS $8.95 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 1/8/2024 8:03:23 AM | View | Presentation | SEC | 1Q 2024 | ||||||
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/9/2023 4:36:38 PM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $924,000 -21.2% | Assets $192,462,000 | EPS -$3.78 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 11/9/2023 4:21:53 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $924,000 -21.2% | Assets $192,462,000 | EPS -$3.78 | Export Earnings Model | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | 9/21/2023 6:06:51 AM | View | Correction | SEC | 2Q 2023 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 8/3/2023 8:15:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $969,000 | Assets $78,638,000 | EPS -$12.73 | |
| Magenta Therapeutics, Inc. (DNTH) | 5/15/2023 4:24:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $476,000 | Assets $83,441,000 | EPS -$8.10 | |
| Magenta Therapeutics, Inc. (DNTH) | 5/1/2023 8:39:41 AM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Rev: $6,417,000 | Assets $83,110,000 | EPS -$32.57 | |
| Magenta Therapeutics, Inc. (DNTH) | 3/23/2023 8:29:47 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $6,417,000 | Assets $83,110,000 | EPS -$32.57 | |
| Magenta Therapeutics, Inc. (DNTH) | 2/7/2023 4:15:06 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $1,175,000 | Assets $83,110,000 | EPS -$11.57 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 11/3/2022 9:27:58 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,173,000 | Assets $164,123,000 | EPS -$8.90 | |
| Magenta Therapeutics, Inc. (DNTH) | 11/3/2022 9:07:57 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $1,173,000 | Assets $164,123,000 | EPS -$8.90 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 8/4/2022 8:39:33 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $175,121,000 | EPS -$0.29 | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/4/2022 8:25:43 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $175,121,000 | EPS -$0.29 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/16/2022 9:17:30 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $194,385,000 | EPS -$0.39 | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/16/2022 9:05:58 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $194,385,000 | EPS -$0.39 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/2/2022 4:04:41 PM | View | Proxy | SEC | Y 2021 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 3/8/2022 8:40:50 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $9,451,000 | EPS -$15.01 | ||
| Magenta Therapeutics, Inc. (DNTH) | 3/8/2022 8:27:46 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $9,451,000 | EPS -$14.04 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 1/10/2022 8:16:09 AM | View | Financials | Earnings (Prelim) | SEC | Y 2021 | Export Earnings Model | ||||
| Magenta Therapeutics, Inc. (DNTH) | 11/4/2021 9:20:40 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $206,236,000 | EPS -$0.30 | ||
| Magenta Therapeutics, Inc. (DNTH) | 11/4/2021 9:11:49 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $206,236,000 | EPS -$0.30 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/5/2021 8:22:52 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $220,378,000 | EPS -$0.32 | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/5/2021 8:13:54 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $220,378,000 | EPS -$0.32 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 7/27/2021 4:56:22 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2021 | Export Earnings Model | ||||
| Magenta Therapeutics, Inc. (DNTH) | 5/6/2021 8:22:29 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $144,620,000 | EPS -$0.36 | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/6/2021 8:11:56 AM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $144,620,000 | EPS -$0.36 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 4/21/2021 8:02:46 AM | View | Proxy | SEC | Y 2020 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 3/3/2021 8:32:21 AM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $161,619,000 | EPS -$1.71 | ||
| Magenta Therapeutics, Inc. (DNTH) | 3/3/2021 8:17:51 AM | View | Financials | Earnings | SEC | Y 2020 | Assets $161,619,000 | EPS -$0.37 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 1/11/2021 8:17:25 AM | View | Financials | Earnings (Prelim) | SEC | Y 2020 | Export Earnings Model | ||||
| Magenta Therapeutics, Inc. (DNTH) | 11/5/2020 8:34:45 AM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $174,641,000 | EPS -$0.37 | ||
| Magenta Therapeutics, Inc. (DNTH) | 11/5/2020 8:19:21 AM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $174,641,000 | EPS -$0.37 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/6/2020 8:39:49 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $190,727,000 | EPS -$0.48 | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/6/2020 8:15:57 AM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $190,727,000 | EPS -$0.48 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/7/2020 7:52:51 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $144,441,000 | EPS -$0.51 | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/7/2020 7:41:00 AM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $144,441,000 | EPS -$0.51 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 4/24/2020 8:03:52 AM | View | Proxy | SEC | Y 2019 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 3/3/2020 8:35:15 AM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $161,514,000 | EPS -$2.07 | ||
| Magenta Therapeutics, Inc. (DNTH) | 3/3/2020 8:18:40 AM | View | Financials | Earnings | SEC | Y 2019 | Assets $161,514,000 | EPS -$0.59 | Export Earnings Model | ||
| Magenta Therapeutics, Inc. (DNTH) | 1/13/2020 8:18:19 AM | View | Presentation | SEC | Y 2020 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 11/13/2019 8:45:22 AM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $177,233,000 | EPS -$0.54 | ||
| Magenta Therapeutics, Inc. (DNTH) | 11/13/2019 8:21:28 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $0 | Assets $177,233,000 | EPS -$0.54 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 8/8/2019 8:28:32 AM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $195,441,000 | EPS -$0.48 | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/8/2019 8:14:56 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $0 | Assets $195,441,000 | EPS -$0.48 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 5/9/2019 8:31:42 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $147,692,000 | EPS -$0.44 | ||
| Magenta Therapeutics, Inc. (DNTH) | 5/9/2019 8:10:07 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $0 | Assets $147,692,000 | EPS -$0.44 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 4/25/2019 4:37:30 PM | View | Proxy | SEC | Y 2018 | ||||||
| Magenta Therapeutics, Inc. (DNTH) | 3/19/2019 7:54:23 AM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $157,313,000 | EPS -$3.13 | ||
| Magenta Therapeutics, Inc. (DNTH) | 3/19/2019 7:42:24 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $0 | Assets $157,313,000 | EPS -$0.50 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 11/8/2018 8:27:57 AM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $172,793,000 | EPS -$0.49 | ||
| Magenta Therapeutics, Inc. (DNTH) | 11/8/2018 8:13:47 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $0 | Assets $172,793,000 | EPS -$0.49 | Export Earnings Model | |
| Magenta Therapeutics, Inc. (DNTH) | 8/9/2018 4:36:13 PM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $180,618,000 | EPS -$3.13 | ||
| Magenta Therapeutics, Inc. (DNTH) | 8/9/2018 4:21:09 PM | View | Earnings | SEC | 2Q 2018 | Rev $0 | Assets $180,618,000 | EPS -$3.13 |